The trip of a lifetime: hallucinogen persisting perceptual disorder
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Objectives: The differential diagnosis of psychotic symptoms is broad and extends beyond primary psychotic and affective disorders. We aim to illustrate that the chronology and phenomenological nature of hallucinatory symptoms may provide clues towards alternative diagnoses, such as hallucinogen persisting perceptual disorder (HPPD). We describe the resurgence of visual pseudo-hallucinations in a young woman in the context of previous substance-induced hallucinatory symptoms and a prior diagnosis of occipital lobe epilepsy. She presented a diagnostic challenge, saw several emergency and specialist doctors and attracted stigmatising diagnoses leading to anxiety and depressive symptoms. Her symptoms were finally recognised as HPPD, and she was treated appropriately with lamotrigine. Conclusions: Patients with perceptual disturbance can present in various clinical settings, and HPPD is an under-recognised diagnostic possibility. Delayed or misdiagnosis prolongs profound functional impairment and social decline, and predisposes the patient to the development of anxiety and depression and related increased risk of suicide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Persistent hallucinosis following repeated administration of hallucinogenic drugs.
ROSENTHAL, S. H. (1964) · American Journal of Psychiatry · doi:10.1176/ajp.121.3.238 · Cited by 82
Cited by
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M., Lorusso, M., Di Giannantonio, M., & Lerner, A. (2018) · Brain Sciences · doi:10.3390/brainsci8030047 · Cited by 171
“Zobor, 2015 [29] 1 Cannabis Gaillard, 2003 [46] 2 Cannabis Lerner, 2014 [47] 2 Cannabis (Synthetic) Anderson, 2017 [48] 1 Cannabis and MDMA Stress Brodrick, 2016 [49] 1 Cannabis and LSD Coppola, 2017 [50] 1 Cannabis (Synthetic, JWH-122) Cannabis consumption Lerner, 2003 [51] 16 LSD Lerner, 2002 [20] 1 LSD Lerner, 2000…”
BackgroundInfluentialHallucinogenic persisting perception disorder: a case series and review of the literature.
Ford, H., Fraser, C. L., Solly, E., Clough, M., Fielding, J., White, O., & Van Der Walt, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.878609 · Cited by 28
Doyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., et al. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2063273 · Cited by 27
Pharmacological Treatment of Hallucinogen Persisting Perception Disorder (HPPD): A Systematic Review
Neven, A., & Blom, J. D. (2025) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000439 · Cited by 4
Metadata
- Authors
- Anderson, L., Lake, H., & Walterfang, M.
- Venue
- Australasian Psychiatry
- Publisher
- SAGE Publications
- Published
- 2017-08-24
- Volume
- 26
- Issue
- 1
- Pages
- 11-12
- ISSN
- 1039-8562 (ISSN-L)
- 1440-1665
- OpenAlex
- W2749574850
- Cited by
- 13
- References
- 1
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The trip of a lifetime: hallucinogen persisting perceptual disorder. https://app.cochat.ai/papers/10.1177/1039856217726694
- The paper
- Anderson, L., Lake, H., & Walterfang, M. (2018). The trip of a lifetime: hallucinogen persisting perceptual disorder. Australasian Psychiatry. https://doi.org/10.1177/1039856217726694
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.